
A Breakthrough on the Horizon: PACAP-Targeting Antibodies Offer New Promise for Migraine Prevention
Early trials of Lu AG09222, an antibody against PACAP, show promise for prevention.

Early trials of Lu AG09222, an antibody against PACAP, show promise for prevention.

A 2024 study mapped how common 29 symptoms are across each migraine phase.

What white matter lesions mean for people with migraine, based on current research.

Real-world data on the side effects people report with gepants.

The link between a patent foramen ovale and migraine, and what it means for stroke risk.

HeadaTerm 2

A visual guide to how cortical spreading depression sets off migraine pain.

Our 150-page guide to understanding and managing migraine, in print.

Sildenafil triggered attacks even with CGRP blocked, pointing to a cGMP pathway.

How to tell migraine aura from a TIA, and the red flags that need urgent care.

A study suggests strict routine may not help chronic migraine in the long run.

In one study, about 3% on CGRP antibodies had ECG changes or heart-related events.